Journal of Antimicrobial Chemotherapy (2000) 46, 23-27
© 2000 The British Society for Antimicrobial Chemotherapy
Treatment options for acute uncomplicated cystitis in adults
Urological Clinic, Hospital St Elisabeth, Straubing, Teaching Hospital of the Technical University of Munich, Germany
Urinary tract infection (UTI) is classified as uncomplicated if it occurs in a patient with a structurally and functionally normal urinary tract. Acute uncomplicated cystitis is observed chiefly in women. It needs, however, to be differentiated depending on whether it occurs in premenopausal, postmenopausal or pregnant women. Only a small number of 15–50 year old, otherwise healthy men suffer acute uncomplicated cystitis. In premenopausal, non-pregnant women, single-dose antimicrobial therapy is generally less effective than the same antibiotic used for longer duration. However, most antimicrobial agents given for 3 days are as effective as those given for longer duration, and adverse events tend to be found more often with longer treatment. Trimethoprim (or co-trimoxazole) can be recommended as first-line empirical therapy only in communities with resistance rates of uropathogens to trimethoprim of 
10–20%. Otherwise fluoroquinolones are recommended. Alternatives are fosfomycin trometamol or ß-lactams, such as second- or third-generation oral cephalosprins or pivmecillinam, especially when fluoroquinolones are contraindicated or a high proportion (>10%) of Escherichia coli strains in the community are already resistant to fluoroquinolones, as in Spain, for example. Recurrent UTIs are common among young, healthy women even though they generally have anatomically and physiologically normal urinary tracts. The following prophylactic antimicrobial regimens are recommended: (i) the use of long-term, low-dose prophylactic antimicrobials taken at bedtime; (ii) post-coital prophylaxis for women in whom episodes of infection are associated with sexual intercourse. Other prophylactic methods are not as yet as effective as antimicrobial prophylaxis.
* Corresponding author. Tel: +49-9421-7101700; Fax: +49-9421-710270; E-mail: naberk{at}klinikum-straubing.de
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. K. Olofsson, L. L. Marcusson, A. Stromback, D. Hughes, and O. Cars Dose-related selection of fluoroquinolone-resistant Escherichia coli J. Antimicrob. Chemother., October 1, 2007; 60(4): 795 - 801. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Galatti, A. Sessa, G. Mazzaglia, S. Pecchioli, A. Rossi, C. Cricelli, G. C. Schito, G. Nicoletti, and A. P. Caputi Antibiotic prescribing for acute and recurrent cystitis in primary care: a 4 year descriptive study J. Antimicrob. Chemother., March 1, 2006; 57(3): 551 - 556. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. K. Lindgren, L. L. Marcusson, D. Sandvang, N. Frimodt-Moller, and D. Hughes Biological Cost of Single and Multiple Norfloxacin Resistance Mutations in Escherichia coli Implicated in Urinary Tract Infections Antimicrob. Agents Chemother., June 1, 2005; 49(6): 2343 - 2351. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Komp Lindgren, A. Karlsson, and D. Hughes Mutation Rate and Evolution of Fluoroquinolone Resistance in Escherichia coli Isolates from Patients with Urinary Tract Infections Antimicrob. Agents Chemother., October 1, 2003; 47(10): 3222 - 3232. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Kuti, P. K. Dandekar, C. H. Nightingale, and D. P. Nicolau Use of Monte Carlo Simulation to Design an Optimized Pharmacodynamic Dosing Strategy for Meropenem J. Clin. Pharmacol., October 1, 2003; 43(10): 1116 - 1123. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Ruiz, K. Simon, J. P. Horcajada, M. Velasco, M. Barranco, G. Roig, A. Moreno-Martinez, J. A. Martinez, T. Jimenez de Anta, J. Mensa, et al. Differences in Virulence Factors among Clinical Isolates of Escherichia coli Causing Cystitis and Pyelonephritis in Women and Prostatitis in Men J. Clin. Microbiol., December 1, 2002; 40(12): 4445 - 4449. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. C. McDonald, F.-J. Chen, H.-J. Lo, H.-C. Yin, P.-L. Lu, C.-H. Huang, P. Chen, T.-L. Lauderdale, and M. Ho Emergence of Reduced Susceptibility and Resistance to Fluoroquinolones in Escherichia coli in Taiwan and Contributions of Distinct Selective Pressures Antimicrob. Agents Chemother., November 1, 2001; 45(11): 3084 - 3091. [Abstract] [Full Text] [PDF]
|
|